ENCO Pharmaceutical Development Announces Addition of Keith Hurley as Vice-President of Sales and Marketing

Jacksonville, FL, - Mr. Hurley joins the growing pharmaceutical contract organization as the company continues its expansion plans. “We are delighted to have someone with Keith’s background in the pharmaceutical and medical device industries join our team”, said Mr. Rick Camp, President of Enco Pharmaceutical Development, Inc. “He brings a wealth of knowledge and has already proven to be a great asset to the company.”

Mr. Hurley has 25 years of experience in the field of science, including 14 years directly in the pharmaceutical industry. He has extensive experience in both laboratory and business operations. “Keith’s broad exposure to so many disciplines within the pharmaceutical industry gives us a multi-faceted resource for our company. We are leveraging these resources not just in business but also in the technical and regulatory areas as well”, said Mr. Camp.

Prior to joining ENCO, Mr. Hurley founded Aspire Pharmaceutical Consulting, Inc., a successful consulting firm where he serves as President. He also has held key positions at Cardinal Health, where he was Global Head of Marketing for the Inhalation Division and at other contract organizations where he has held a variety of positions from Director to Vice-President. Mr. Hurley has also worked at Aradigm, Novartis and Proctor and Gamble. Mr. Hurley has been actively involved in a wide variety of pharmaceutical conferences around the world where he has either presented, chaired or led discussion forums. He is also a member of AAPS.

ENCO Pharmaceutical Development, Inc. provides technical outsourcing assistance to the pharmaceutical industry, including analytical product development with services that range from raw materials testing to full Phase III stability studies following cGMP standards. The company also provides comprehensive testing on medical devices. ENCO is FDA registered, an ISO accredited analytical laboratory and holds registration with the DEA to handle the development of controlled drug substance for pharmaceutical use. ENCO Pharmaceutical Development, Inc. operates two locations – the corporate headquarters at 4810 Executive Park Ct., Suite 110, Jacksonville, FL and a second location at 102-E Woodwinds Industrial Ct, Cary, NC 27511

ENCO Analytix, Inc, Announces Name Change to ENCO Pharmaceutical Development, Inc.

Jacksonville, FL, - The articles governing the amendment to change the company name were officially received in the offices of ENCO from the state of Florida on April 30, 2009. “We are very excited about the name change as it more accurately reflects our sole focus on the pharmaceutical industry”, said Rick Camp, President of ENCO Pharmaceutical Development, Inc. “We have worked hard over the past 5 years to develop a very positive reputation with our customers within the pharmaceutical and medical device industries and we believe that this change in name will make it easier for new customers to understand our service offerings”, Camp said.

The name change will be evident immediately on all ENCO Analytix, Inc. corporate documents, signage and references. “ENCO Pharmaceutical Development, Inc. is a better descriptor of the services that our company offers” said, Keith Hurley, Vice-President of Sales and Marketing. “We are a dynamic and growing company offering a unique service approach to the pharmaceutical outsourcing industry”, Hurley said. “It’s part of the marketing plan, we want to make sure those companies that are in search of an outsourcing partner to handle their analytical development needs, know that we are here to work with them”, said Hurley.

For additional information on the name change of ENCO Analytix, Inc. to ENCO Pharmaceutical Development, Inc., please contact Keith Hurley, Vice-President of Sales and Marketing at 336.541.3270

About ENCO Pharmaceutical Development, Inc.

ENCO Pharmaceutical Development, Inc. provides technical outsourcing assistance to the pharmaceutical industry, including analytical product development with services that range from raw materials testing to full Phase III stability studies following cGMP standards. The company also provides comprehensive testing on medical devices. ENCO is FDA registered, an ISO accredited analytical laboratory and holds registration with the DEA to handle the development of controlled drug substance for pharmaceutical use. ENCO Pharmaceutical Development, Inc. operates two locations – the corporate headquarters at 4810 Executive Park Ct., Suite 110, Jacksonville, FL and a second location at 102-E Woodwinds Industrial Ct, Cary, NC 27511